Originally Posted by
MAC
It’s not so much the starter sales that they are talking about Blobbles, starter sales while hiring staff are really not that important within the big picture, it’s the traction made against the commercial roll out plan that they follow and seem to be encouraged by.
Professional analysts like Craig’s, Forbar, Edison et al, have access to much greater information than the rest of us it terms of event timing and the number of user programmes etc.
As I understand, the individual urologist user programmes are 25 tests each and roll over after between 3 to 9 months, the larger LUG user programmes which have 100 or so urologists run 12 to 15 months prior to adoption, and the much larger KP user programme again should come to fruition next year.
Then there is CMS revenues accumulating ready to be invoiced, probably IMO once the two present US studies are complete and published to their satisfaction.
So, what the analysts are doing with greater confidence from greater information, is stacking those prospective new user programme revenue streams as a carefully evaluated forecast.
Clearly their consensus is 'up and away' based on the number of user programmes stacking right now.